{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:07:57Z","timestamp":1786399677041,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN 154311"],"award-info":[{"award-number":["FDN 154311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ccc.2018.11.004","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T06:43:20Z","timestamp":1548398600000},"page":"247-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Vasopressin in Vasodilatory Shock"],"prefix":"10.1016","volume":"35","author":[{"given":"Ida-Fong","family":"Ukor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccc.2018.11.004_bib1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1540\/jsmr.43.117","article-title":"Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction","volume":"43","author":"Matsuda","year":"2007","journal-title":"J\u00a0Smooth Muscle Res"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib3","first-page":"1303","article-title":"Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms","volume":"46","author":"Burgdorff","year":"2018","journal-title":"J\u00a0Int Med Res"},{"issue":"5","key":"10.1016\/j.ccc.2018.11.004_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000658-199111000-00013","article-title":"Nitrogen oxide levels in patients after trauma and during sepsis","volume":"214","author":"Ochoa","year":"1991","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ccc.2018.11.004_bib5","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1074\/jbc.M411317200","article-title":"Autoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function","volume":"280","author":"Vo","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1258\/0007142991902286","article-title":"The role of the endothelium in modulating vascular control in sepsis and related conditions","volume":"55","author":"Wort","year":"1999","journal-title":"Br Med Bull"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0301-472X(02)00777-4","article-title":"NF\u03baB-dependent signalling pathways","volume":"30","author":"Li","year":"2002","journal-title":"Exp Hematol"},{"issue":"8","key":"10.1016\/j.ccc.2018.11.004_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/A:1015926119947","article-title":"Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters","volume":"6","author":"Ignarro","year":"1989","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.HYP.12.4.365","article-title":"The discovery of nitric oxide as the endogenous nitrovasodilator","volume":"12","author":"Moncada","year":"1988","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcrc.2013.08.021","article-title":"Vasoplegia in septic shock: do we really fight the right enemy?","volume":"29","author":"Sharawy","year":"2014","journal-title":"J\u00a0Crit Care"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib11","doi-asserted-by":"crossref","first-page":"C235","DOI":"10.1152\/ajpcell.2000.278.2.C235","article-title":"Calcium sparks in smooth muscle","volume":"278","author":"Jaggar","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"10.1016\/j.ccc.2018.11.004_bib12","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1073\/pnas.87.9.3629","article-title":"NG-methyl-l-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide","volume":"87","author":"Kilbourn","year":"1990","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"7","key":"10.1016\/j.ccc.2018.11.004_bib13","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1253\/circj.CJ-12-0197","article-title":"Mechanisms for enhanced endothelium-derived hyperpolarizing factor-mediated responses in microvessels in mice","volume":"76","author":"Ohashi","year":"2012","journal-title":"Circ J"},{"issue":"11","key":"10.1016\/j.ccc.2018.11.004_bib14","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/01.CIR.92.11.3337","article-title":"Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP","volume":"92","author":"Cohen","year":"1995","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ccc.2018.11.004_bib15","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1172\/JCI119826","article-title":"Importance of endothelium-derived hyperpolarizing factor in human arteries","volume":"100","author":"Urakami-Harasawa","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.ccc.2018.11.004_bib16","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1172\/JCI10506","article-title":"Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice","volume":"106","author":"Matoba","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ccc.2018.11.004_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.HYP.35.1.173","article-title":"Ion channels and vascular tone","volume":"35","author":"Jackson","year":"2000","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.1997.77.4.1165","article-title":"ATP-sensitive and inwardly rectifying potassium channels in smooth muscle","volume":"77","author":"Quayle","year":"1997","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01708370","article-title":"Plasma cyclic guanosine 3\u2032\u20135\u2032 monophosphate concentrations and low vascular resistance in human septic shock","volume":"19","author":"Schneider","year":"1993","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0024-3205(94)00416-P","article-title":"Changes in plasma concentrations of vasoactive neuropeptides in patients with sepsis and septic shock","volume":"56","author":"Arnalich","year":"1995","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.ccc.2018.11.004_bib21","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1097\/00003246-200009000-00014","article-title":"High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock","volume":"28","author":"Martin","year":"2000","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2018.11.004_bib22","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI115820","article-title":"The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog","volume":"89","author":"Landry","year":"1992","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.ccc.2018.11.004_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-2007-979841","article-title":"Cardiovascular effects of conventional sulfonylureas and glimepiride","volume":"28","author":"Geisen","year":"1996","journal-title":"Horm Metab Res"},{"issue":"8","key":"10.1016\/j.ccc.2018.11.004_bib24","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/sj.bjp.0702985","article-title":"Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide","volume":"128","author":"Gardiner","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.CCM.0000206114.19707.7C","article-title":"Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock","volume":"34","author":"Warrillow","year":"2006","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccc.2018.11.004_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/shk.0b013e3180556a3c","article-title":"Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport","volume":"28","author":"Morelli","year":"2007","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/ACO.0b013e3282f3ad74","article-title":"Inhibition of potassium channels in critical illness","volume":"21","author":"Lange","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1345\/aph.19066","article-title":"The role of vasopressin in the treatment of vasodilation in shock states","volume":"34","author":"Rozenfeld","year":"2000","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.ccc.2018.11.004_bib29","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside","volume":"36","author":"Levy","year":"2010","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.38.2.177","article-title":"Downregulation of angiotensin II type 1 receptors during sepsis","volume":"38","author":"Bucher","year":"2001","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ccc.2018.11.004_bib31","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1097\/00003246-200109000-00016","article-title":"Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis","volume":"29","author":"Bucher","year":"2001","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2009.10.006","article-title":"Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock","volume":"49","author":"Schmidt","year":"2010","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0b013e3181994752","article-title":"Inhibition of NF-\u03baB activity prevents downregulation of \u03b11-adrenergic receptors and circulatory failure during CLP-induced sepsis","volume":"32","author":"Schmidt","year":"2009","journal-title":"Shock"},{"issue":"9","key":"10.1016\/j.ccc.2018.11.004_bib34","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1097\/CCM.0000000000002462","article-title":"Aldosterone and vascular mineralocorticoid receptors in murine endotoxic and human septic shock","volume":"45","author":"Fadel","year":"2017","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bpa.2008.03.002","article-title":"Arginine vasopressin in the treatment of vasodilatory septic shock","volume":"22","author":"Holmes","year":"2008","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"8","key":"10.1016\/j.ccc.2018.11.004_bib36","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/CCM.0b013e318180b51d","article-title":"Role of nuclear factor-\u039aB-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure","volume":"36","author":"Schmidt","year":"2008","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.CIR.100.3.226","article-title":"Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock","volume":"100","author":"Morales","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","article-title":"Vasopressin: mechanisms of action on the vasculature in health and in septic shock","volume":"35","author":"Barrett","year":"2007","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccc.2018.11.004_bib39","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib40","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.120.3.989","article-title":"Physiology of vasopressin relevant to management of septic shock","volume":"120","author":"Holmes","year":"2001","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/cc2338","article-title":"Science review: vasopressin and the cardiovascular system part 2 \u2013 clinical physiology","volume":"8","author":"Holmes","year":"2004","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1113\/jphysiol.1972.sp010039","article-title":"Vasopressin clearance and secretion during haemorrhage in normal dogs and in dogs with experimental diabetes insipidus","volume":"227","author":"Errington","year":"1972","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ccc.2018.11.004_bib43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0014-2999(81)90583-5","article-title":"Effect of captopril on cardiovascular, sympathetic and vasopressin responses to hemorrhage","volume":"72","author":"Zerbe","year":"1981","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00586258","article-title":"The effects of hypotension and hypovolaemia on the liberation of vasopressin during haemorrhage in the unanaesthetized monkey (macaca mulatta)","volume":"371","author":"Arnauld","year":"1977","journal-title":"Pflugers Arch"},{"issue":"6","key":"10.1016\/j.ccc.2018.11.004_bib45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0301-0082(98)00072-0","article-title":"Physiological pathways regulating the activity of magnocellular neurosecretory cells","volume":"57","author":"Leng","year":"1999","journal-title":"Prog Neurobiol"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib46","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1152\/physrev.1983.63.4.1243","article-title":"Central nervous system mediators of vasopressin release","volume":"63","author":"Sklar","year":"1983","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/geno.1996.0055","article-title":"Structure, sequence, expression, and chromosomal localization of the human v1avasopressin receptor gene","volume":"31","author":"Thibonnier","year":"1996","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.ccc.2018.11.004_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/cc2337","article-title":"Science review: vasopressin and the cardiovascular system part 1 \u2013 receptor physiology","volume":"7","author":"Holmes","year":"2003","journal-title":"Crit Care"},{"issue":"2 Pt 2","key":"10.1016\/j.ccc.2018.11.004_bib49","first-page":"H491","article-title":"Vasopressin modulates K(+)-channel activities of cultured smooth muscle cells from porcine coronary artery","volume":"263","author":"Wakatsuki","year":"1992","journal-title":"Am J Physiol"},{"issue":"6 Pt 2","key":"10.1016\/j.ccc.2018.11.004_bib50","first-page":"R1257","article-title":"Renal cortical and medullary blood flow responses during water restriction: role of vasopressin","volume":"270","author":"Franchini","year":"1996","journal-title":"Am J Physiol"},{"issue":"8","key":"10.1016\/j.ccc.2018.11.004_bib51","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s001340101014","article-title":"The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series","volume":"27","author":"Holmes","year":"2001","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0049-3848(87)90252-0","article-title":"Mechanism of vasopressin-induced platelet aggregation","volume":"45","author":"Filep","year":"1987","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0049-3848(87)90221-0","article-title":"V1a-vasopressin specific receptors on human platelets: potentiation by ADP and epinephrine and evidence for homologous down-regulation","volume":"45","author":"Launay","year":"1987","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.ccc.2018.11.004_bib54","doi-asserted-by":"crossref","first-page":"F931","DOI":"10.1152\/ajprenal.00604.2013","article-title":"The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors","volume":"306","author":"Juul","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0008-6363(01)00328-5","article-title":"Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects","volume":"51","author":"Bankir","year":"2001","journal-title":"Cardiovasc Res"},{"issue":"2 Pt 2","key":"10.1016\/j.ccc.2018.11.004_bib56","first-page":"F204","article-title":"Vasopressin activates collecting duct urea transporters and water channels by distinct physical processes","volume":"265","author":"Nielsen","year":"1993","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib57","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1996.101","article-title":"Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles","volume":"49","author":"Tamaki","year":"1996","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib58","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1538-7836.2003.00197.x","article-title":"Desmopressin (DDAVP) induces no production in human endothelial cells via V2 receptor- and cAMP-mediated signaling","volume":"1","author":"Kaufmann","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.resuscitation.2008.07.006","article-title":"Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R","volume":"79","author":"Boyd","year":"2008","journal-title":"Resuscitation"},{"issue":"9","key":"10.1016\/j.ccc.2018.11.004_bib60","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.ccc.2018.11.004_bib62","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1210\/endo.138.10.5432","article-title":"The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signalling pathways","volume":"138","author":"Thibonnier","year":"2018","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ccc.2018.11.004_bib63","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00004872-199715060-00009","article-title":"Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells","volume":"15","author":"Kusano","year":"1997","journal-title":"J\u00a0Hypertens"},{"issue":"5","key":"10.1016\/j.ccc.2018.11.004_bib64","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/jhep.2002.36501","article-title":"Terlipressin inhibits in\u00a0vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis","volume":"36","author":"Moreau","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.ccc.2018.11.004_bib65","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1399-6576.2004.00418.x","article-title":"Arginine vasopressin and serum nitrite\/nitrate concentrations in advanced vasodilatory shock","volume":"48","author":"Dunser","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1253\/circj.66.277","article-title":"Vasopressin inhibits sarcolemmal ATP-sensitive K+ channels via V1 receptors activation in the Guinea pig heart","volume":"66","author":"Tsuchiya","year":"2002","journal-title":"Circ J"},{"issue":"11","key":"10.1016\/j.ccc.2018.11.004_bib67","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/01.RES.87.11.1019","article-title":"Calcium modulation of vascular smooth muscle ATP-sensitive K+ channels: role of protein phosphatase-2B","volume":"87","author":"Wilson","year":"2000","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","article-title":"Depletion of neurohypophyseal content of vasopressin in septic shock","volume":"30","author":"Sharshar","year":"2002","journal-title":"Crit Care Med"},{"issue":"9398","key":"10.1016\/j.ccc.2018.11.004_bib69","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(03)14899-4","article-title":"Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock","volume":"362","author":"Sharshar","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/frne.1994.1014","article-title":"Role of nitric oxide in the regulation of renin and vasopressin secretion","volume":"15","author":"Reid","year":"1994","journal-title":"Front Neuroendocrinol"},{"issue":"6","key":"10.1016\/j.ccc.2018.11.004_bib71","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/00003246-200206000-00025","article-title":"Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock","volume":"30","author":"Giusti-Paiva","year":"2002","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2018.11.004_bib72","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00424-005-1400-z","article-title":"Vasopressin release during endotoxaemic shock in mice lacking inducible nitric oxide synthase","volume":"450","author":"Carnio","year":"2005","journal-title":"Pflugers Arch"},{"issue":"5","key":"10.1016\/j.ccc.2018.11.004_bib73","first-page":"446","article-title":"Vasopressin and its immune effects in septic shock","volume":"2","author":"Russell","year":"2010","journal-title":"J\u00a0Innate Immun"},{"issue":"7","key":"10.1016\/j.ccc.2018.11.004_bib74","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s00134-009-1470-z","article-title":"Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock","volume":"35","author":"Rehberg","year":"2009","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.ccc.2018.11.004_bib75","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s00134-016-4269-8","article-title":"Vasopressors in shock: are we meeting our target and do we really understand what we are aiming at?","volume":"42","author":"D\u00fcnser","year":"2016","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bpa.2016.10.010","article-title":"Effect of non-adrenergic vasopressors on macro- and microvascular coupling in distributive shock","volume":"30","author":"Hessler","year":"2016","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCM.0000000000001380","article-title":"A\u00a0selective V1A receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock","volume":"44","author":"He","year":"2016","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccc.2018.11.004_bib78","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1186\/cc10453","article-title":"Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock","volume":"15","author":"Morelli","year":"2011","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib79","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/SHK.0000000000000864","article-title":"Neuroendocrine derangements in early septic shock: pharmacotherapy for relative adrenal and vasopressin insufficiency","volume":"48","author":"Schurr","year":"2017","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2018.11.004_bib81","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock","volume":"37","author":"Russell","year":"2009","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccc.2018.11.004_bib82","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccc.2018.11.004_bib83","doi-asserted-by":"crossref","first-page":"R181","DOI":"10.1186\/cc8167","article-title":"Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial","volume":"13","author":"D\u00fcnser","year":"2009","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.ccc.2018.11.004_bib84","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2018.11.004_bib85","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study","volume":"13","author":"Morelli","year":"2009","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib86","doi-asserted-by":"crossref","first-page":"e29693","DOI":"10.1371\/journal.pone.0029693","article-title":"The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis","volume":"7","author":"Ishikawa","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ccc.2018.11.004_bib87","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00134-007-0946-y","article-title":"Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis","volume":"34","author":"Lange","year":"2008","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2018.11.004_bib88","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bpa.2008.03.005","article-title":"Arginine vasopressin vs. terlipressin in the treatment of shock states","volume":"22","author":"Singer","year":"2008","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"1","key":"10.1016\/j.ccc.2018.11.004_bib89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit Care"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070418307723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070418307723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:02:47Z","timestamp":1760061767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070418307723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0749070418307723"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2018.11.004","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasopressin in Vasodilatory Shock","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}